At the Cancer Institute of Prisma Health, our core philosophy is anchored in providing the most effective, most targeted cancer care available in the world. We are dedicated to enhancing the quality of life for those with cancer in our community and beyond through clinical excellence and research.
We understand that cancer care is about comfort, compassion and enhanced access to care, so we focus on treating the whole person, not just the disease. This means patients do not have to leave the Upstate to receive high-quality cancer care. In fact, many people travel to Prisma Health Cancer Institute from outside our state to receive care.
Click here to subscribe to our eNewsletter for news and updates from the Cancer Institute.
With a focus on translating research to personalized cancer treatment, Prisma Health’s Institute for Translational Oncology Research (ITOR) provides some of the most advanced cancer treatments available anywhere in the world.
Our Multidisciplinary Center (MDC) brings together a number of specialists and care providers in one place, allowing a patient to accomplish in one morning visit what previously may have taken several trips over a few weeks.
Prisma Health’s Center for Integrative Oncology and Survivorship (CIOS) is a patient-centered program that integrates evidenced-based complementary therapies with traditional cancer care to treat the “whole patient,” encompassing mind, body and spirit.
The National Cancer Institute proclaimed Prisma Health Cancer Institute among the nation’s best in research with an award of $8.2 million to conduct clinical trials and research studies aimed at improving patient outcomes and reducing health disparities. The grant helps pave the way for more clinical trials and innovative therapies and will allow Prisma Health Cancer Institute to expand its groundbreaking cancer research into the Midlands. The additional clinical trials in the Midlands will launch this fall and initially target lymphomas, leukemia and solid tumors.
Prisma Health Cancer Institute is one of only 32 programs in the nation to receive a grant from the NCI’s Community Oncology Program (NCORP). Clinical trials focus on improving cancer prevention, cancer control, screening for early cancers, and post-treatment surveillance. Cancer care delivery research will focus on quality of life and understanding the diverse and multi-level factors that affect access and quality of care. The recent grant is for a six-year funding period. Since 1995, Prisma Health—Upstate has received more than $30 million in research grants from the National Institute of Cancer, considered the preeminent cancer research funder in the world.
1000th BMT PatientPrisma Health’ss Cancer Institute marked its 1000th stem cell transplant in October, a major milestone of providing 25 years of innovative transplant therapies in the Upstate. Learn more here.
The Prisma Health Cancer Institute has received FACT accreditation for allogeneic stem cell transplantation. The Cancer Institute is one of only two programs in the state and the only program in the Upstate to earn FACT accreditation for both allogeneic and autologous stem cell transplants.
“Mom was active at 83—right up until she was diagnosed with cancer. During the next five years of treatments and hospital stays, one thing stands out: the amazing kindness and compassion of the doctors, nurses and staff of the Prisma Health Cancer Institute.
The care she received inspired us to give back. Then we learned about the blood and marrow transplant (BMT) unit—and how having the unit right here means patients don’t leave families, homes and jobs for weeks at a time. I had no idea…”
Discover here what amazes Gary.